247 related articles for article (PubMed ID: 18223471)
21. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
[TBL] [Abstract][Full Text] [Related]
22. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
[TBL] [Abstract][Full Text] [Related]
23. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
24. Concentrations of vancomycin in human bone.
Borner K; Hahn F; Koeppe P
J Chemother; 1989 Jul; 1(4 Suppl):588-9. PubMed ID: 16312546
[No Abstract] [Full Text] [Related]
25. The appropriateness of initial vancomycin dosing.
Rodman DP; McKnight JT; Rogers T; Robbins M
J Fam Pract; 1994 May; 38(5):473-7. PubMed ID: 8176345
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment.
Moffett BS; Cannon BC; Friedman RA; Kertesz NJ
Pharmacotherapy; 2006 Dec; 26(12):1687-93. PubMed ID: 17125432
[TBL] [Abstract][Full Text] [Related]
27. Vancomycin pharmacokinetics in middle-aged and elderly men.
Leonard AE; Boro MS
Am J Hosp Pharm; 1994 Mar; 51(6):798-800. PubMed ID: 8010319
[TBL] [Abstract][Full Text] [Related]
28. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
Pea F; Furlanut M; Negri C; Pavan F; Crapis M; Cristini F; Viale P
Antimicrob Agents Chemother; 2009 May; 53(5):1863-7. PubMed ID: 19223642
[TBL] [Abstract][Full Text] [Related]
29. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
[TBL] [Abstract][Full Text] [Related]
30. Computer dosing program for the initiation of vancomycin therapy.
Ito MK; Duren LL; Simonian JS; Dreyfus-Vigil SD; Cookson TL
Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
[TBL] [Abstract][Full Text] [Related]
33. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
34. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
[TBL] [Abstract][Full Text] [Related]
35. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Jeurissen A; Sluyts I; Rutsaert R
Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
[TBL] [Abstract][Full Text] [Related]
36. Impact of ibuprofen administration on renal drug clearance in the first weeks of life.
Allegaert K; Rayyan M; Anderson BJ
Methods Find Exp Clin Pharmacol; 2006 Oct; 28(8):519-22. PubMed ID: 17136231
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients.
Suzuki A; Imanishi Y; Nakano S; Niwa T; Ohmori T; Shirai K; Yoshida S; Furuta N; Takemura M; Ito H; Ieiri I; Seishima M; Ogura S; Itoh Y
J Pharm Pharmacol; 2010 Jul; 62(7):901-7. PubMed ID: 20636878
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation.
Mulla H; Pooboni S
Br J Clin Pharmacol; 2005 Sep; 60(3):265-75. PubMed ID: 16120065
[TBL] [Abstract][Full Text] [Related]
39. Decreased vancomycin clearance in patients with congestive heart failure.
Shimamoto Y; Fukuda T; Tominari S; Fukumoto K; Ueno K; Dong M; Tanaka K; Shirasaka T; Komori K
Eur J Clin Pharmacol; 2013 Mar; 69(3):449-57. PubMed ID: 22791272
[TBL] [Abstract][Full Text] [Related]
40. Release of vancomycin and teicoplanin from a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides.
Drognitz O; Thorn D; Krüger T; Gatermann SG; Iven H; Bruch HP; Muhl E
Infection; 2006 Feb; 34(1):29-34. PubMed ID: 16501900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]